Alimentiv and Summit collaborate to tackle liver disease NASH
Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit Clinical Research to tackle NASH.
Stay updated with breaking news from Hershell Thompson. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Drug development programs will be driven forward by a collaboration between Alimentiv Inc. and Summit Clinical Research to tackle NASH.
LONDON, ON, Nov. 3, 2022 /PRNewswire/ -- Alimentiv Inc. ("Alimentiv") and Summit Clinical Research, LLC ("Summit") today announced a strategic alliance to drive Non-Alcoholic Steatohepatitis
/PRNewswire/ - Alimentiv Inc. ("Alimentiv") and Summit Clinical Research, LLC ("Summit") today announced a strategic alliance to drive Non-Alcoholic...
LONDON, ON, Nov. 3, 2022 /PRNewswire/ - Alimentiv Inc. ('Alimentiv') and Summit Clinical Research, LLC ('Summit') today announced a strategic alli...